ZYXI
To be clear if your short-term in nature $2.50 might have been a good sale point. But I'm looking to add more on weakness. I like this one longer run. I think 2018 could be an amazing year for this one. if I had a trading position along with my 2% position I would of definetley took some profits on this one when it hit $2.50, but since I didn't I didn't want to risk it.
Keep in mind interest expense was abnormally high in q3, and in my opinion will not be anywhere near that level in future quarters. So IE, ate up about .02 of profits in q3 keep that in mind. Now I do admit taxes are coming soon, but if this tax bill gets approved and I think it will the tax rate will not be substancial for these guys and the interest expense change will take care of the tax rate, Hence we are probably looking at a company that can do .30 right now fully taxed in 2018, and that is without any growth. a growing medical company like this one would go for about $4.50-$5 easy, keep in mind that is on the fundies now and they are growing rapidly. So i think the stock could double maybe more in 2018. Now does that mean I'm a seller before hand sure, but not in the mid 2's. Keep in mind if they get approval for that new device that changes everything for this company and could be a possible game changer as well, if anything I'm looking to buy more shares not sell the ones I have still regret not hitting the ask at $2.15 yesterday when the buyback was announced. All is just my opinion, and I could always be wrong though.
